Brand Asset Management Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-973
| Closed | -$29K | – | 102 |
|
|
2021
Q1 | $29K | Hold |
973
| – | – | 0.01% | 171 |
|
|
2020
Q4 | $31K | Hold |
973
| – | – | 0.02% | 150 |
|
|
2020
Q3 | $27K | Hold |
973
| – | – | 0.02% | 158 |
|
|
2020
Q2 | $26K | Hold |
973
| – | – | 0.02% | 158 |
|
|
2020
Q1 | $19K | Hold |
973
| – | – | 0.01% | 170 |
|
|
2019
Q4 | $23K | Hold |
973
| – | – | 0.01% | 185 |
|
|
2019
Q3 | $18K | Hold |
973
| – | – | 0.01% | 194 |
|
|
2019
Q2 | $21K | Hold |
973
| – | – | 0.01% | 195 |
|
|
2019
Q1 | $20K | Buy |
+973
| New | +$20K | 0.01% | 179 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$25K | – | 235 |
|
|
2018
Q3 | $25K | Hold |
1,000
| – | – | 0.02% | 164 |
|
|
2018
Q2 | $24K | Buy |
+1,000
| New | +$24K | 0.02% | 170 |
|